Lee, H.* ; Aylward, A.J.* ; Pearse, R.V.* ; Lish, A.M.* ; Hsieh, Y.C.* ; Augur, Z.M.* ; Benoit, C.R.* ; Chou, V.* ; Knupp, A.* ; Pan, C.* ; Goberdhan, S.* ; Duong, D.M.* ; Seyfried, N.T.* ; Bennett, D.A.* ; Taga, M.F.* ; Huynh, K.* ; Arnold, M. ; Meikle, P.J.* ; de Jager, P.L.* ; Menon, V.* ; Young, J.E.* ; Young-Pearse, T.L.*
Cell-type-specific regulation of APOE and CLU levels in human neurons by the Alzheimer's disease risk gene SORL1.
Cell Rep. 42:112994 (2023)
SORL1 is implicated in the pathogenesis of Alzheimer's disease (AD) through genetic studies. To interrogate the roles of SORL1 in human brain cells, SORL1-null induced pluripotent stem cells (iPSCs) were differentiated to neuron, astrocyte, microglial, and endothelial cell fates. Loss of SORL1 leads to alterations in both overlapping and distinct pathways across cell types, with the greatest effects in neurons and astrocytes. SORL1 loss induces a neuron-specific reduction in apolipoprotein E (APOE) and clusterin (CLU) and altered lipid profiles. Analyses of iPSCs derived from a large cohort reveal a neuron-specific association between SORL1, APOE, and CLU levels, a finding validated in postmortem brain. Enhancement of retromer-mediated trafficking rescues tau phenotypes observed in SORL1-null neurons but does not rescue APOE levels. Pathway analyses implicate transforming growth factor β (TGF-β)/SMAD signaling in SORL1 function, and modulating SMAD signaling in neurons alters APOE RNA levels in a SORL1-dependent manner. Taken together, these data provide a mechanistic link between strong genetic risk factors for AD.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Apoe ; Alzheimer's ; Clu ; Cp: Neuroscience ; Smad ; Sorl1 ; Tgfbeta ; Amyloid ; Endolysosomal ; Retromer ; Tau; Apolipoprotein-e; Amyloid-beta; Lr11/sorla Expression; Receptor Lr11; Association; Sorla/lr11; Mutations; Retromer; Biology; Model
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2023
Prepublished im Jahr
0
HGF-Berichtsjahr
2023
ISSN (print) / ISBN
2211-1247
e-ISSN
2211-1247
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 42,
Heft: 8,
Seiten: ,
Artikelnummer: 112994
Supplement: ,
Reihe
Verlag
Cell Press
Verlagsort
50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30205 - Bioengineering and Digital Health
Forschungsfeld(er)
Enabling and Novel Technologies
PSP-Element(e)
G-503891-001
Förderungen
NIH
Copyright
Erfassungsdatum
2023-10-06